Does USTEKINUMAB-STBA Cause Intentional dose omission? 21 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Intentional dose omission have been filed in association with USTEKINUMAB-STBA. This represents 11.4% of all adverse event reports for USTEKINUMAB-STBA.
21
Reports of Intentional dose omission with USTEKINUMAB-STBA
11.4%
of all USTEKINUMAB-STBA reports
1
Deaths
9
Hospitalizations
How Dangerous Is Intentional dose omission From USTEKINUMAB-STBA?
Of the 21 reports, 1 (4.8%) resulted in death, 9 (42.9%) required hospitalization.
Is Intentional dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB-STBA. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB-STBA Cause?
Intentional product use issue (46)
Off label use (43)
Crohn's disease (20)
Death (15)
Haematochezia (13)
Condition aggravated (12)
Diarrhoea (10)
Colitis ulcerative (8)
Psoriasis (8)
Abdominal pain (6)
What Other Drugs Cause Intentional dose omission?
DUPILUMAB (2,269)
CERTOLIZUMAB PEGOL (1,253)
ADALIMUMAB (845)
TOFACITINIB (845)
INFLIXIMAB (815)
ABALOPARATIDE (623)
ETANERCEPT (615)
AMBRISENTAN (595)
SODIUM OXYBATE (580)
CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (518)
Which USTEKINUMAB-STBA Alternatives Have Lower Intentional dose omission Risk?
USTEKINUMAB-STBA vs VADADUSTAT
USTEKINUMAB-STBA vs VALACYCLOVIR
USTEKINUMAB-STBA vs VALBENAZINE
USTEKINUMAB-STBA vs VALBENAZINE DITOSYLATE
USTEKINUMAB-STBA vs VALDECOXIB